{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:41:46Z","timestamp":1761986506236},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.bulcan.2017.06.014","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T23:00:19Z","timestamp":1501628419000},"page":"814-816","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Induction de tol\u00e9rance apr\u00e8s toxidermie au l\u00e9nalidomide au cours d\u2019un syndrome 5q-"],"prefix":"10.1016","volume":"104","author":[{"given":"Laurys","family":"Boudin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Patient","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Rom\u00e9o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-S\u00e9bastien","family":"Blad\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"de Jaur\u00e9guiberry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bulcan.2017.06.014_bib0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/bjh.14193","article-title":"Multiple myeloma: practice patterns across Europe","volume":"175","author":"Raab","year":"2016","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.bulcan.2017.06.014_bib0060","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1200\/JCO.2015.63.5904","article-title":"Mantle cell lymphoma","volume":"34","author":"Cheah","year":"2016","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2017.06.014_bib0065","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.clml.2013.03.006","article-title":"Risk of rash associated with lenalidomide in cancer patients: a systematic review of the literature and meta-analysis","volume":"13","author":"Nardone","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"10.1016\/j.bulcan.2017.06.014_bib0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/bjh.12925","article-title":"Lenalidomide desensitization for delayed hypersensitivity reactions in 5\u00a0patients with multiple myeloma","volume":"167","author":"Lee","year":"2014","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.bulcan.2017.06.014_bib0075","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.clml.2012.09.003","article-title":"Desensitization to lenalidomide in a patient with relapsed multiple myeloma","volume":"13","author":"Seki","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"10.1016\/j.bulcan.2017.06.014_bib0080","first-page":"542","article-title":"[Desensitization to lenalidomide]","volume":"36","author":"Ca\u00f1amares Orbis","year":"2012","journal-title":"Farm Hosp Organo Of Expresion Cient Soc Espanola Farm Hosp"},{"issue":"11","key":"10.1016\/j.bulcan.2017.06.014_bib0085","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/ajh.21004","article-title":"Successful desensitization in a patient with lenalidomide hypersensitivity","volume":"82","author":"Phillips","year":"2007","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.bulcan.2017.06.014_bib0090","doi-asserted-by":"crossref","first-page":"807","DOI":"10.14740\/jocmr2303e","article-title":"Lenalidomide desensitization in systemic light-chain amyloidosis with multi-organ involvement","volume":"7","author":"Seki","year":"2015","journal-title":"J Clin Med Res"},{"issue":"7","key":"10.1016\/j.bulcan.2017.06.014_bib0095","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/all.12161","article-title":"Desensitization in delayed drug hypersensitivity reactions \u2013\u00a0an EAACI position paper of the Drug Allergy Interest Group","volume":"68","author":"Scherer","year":"2013","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.bulcan.2017.06.014_bib0050","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3109\/0284186X.2011.640347","article-title":"Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501\u00a0and HLA-DQB1*0602","volume":"51","author":"Penna","year":"2012","journal-title":"Acta Oncol Stockh Swed"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455117301947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455117301947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T20:52:27Z","timestamp":1535575947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455117301947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0007455117301947"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2017.06.014","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction de tol\u00e9rance apr\u00e8s toxidermie au l\u00e9nalidomide au cours d\u2019un syndrome 5q-","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2017.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}